₹32.7▲1.4%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -10.39 % |
3 Month Return | -17.54 % |
1 Year Return | -17.39 % |
Market Stats | |
Previous Close | ₹32.25 |
Open | ₹33.70 |
Volume | 8,920.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹114.43Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹114.43 Cr |
P/B Ratio | -1.13 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
![]() | NA | ₹114.43 Cr | 68.36% | 1.83 | NA | NA |
![]() | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
![]() | NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
![]() | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
![]() | NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Organisation | Oxygenta Pharmaceutical Ltd |
Headquarters | Hyderabad |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Oxygenta Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Up
Promoters have increased holdings from 29.73% to 33.69% in Jun 2024 quarter
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 104.6%
Price Dip
In the last 3 months, Oxygenta Pharma stock has moved down by -17.5%
Retail Holding Down
Retail Investor have decreased holdings from 70.25% to 66.29% in Jun 2024 quarter
2023 | Y/Y Change | |
---|---|---|
Total Assets | ₹54.26Cr | ↑74.08% |
Total Liabilities | ₹100.46Cr | ↑52.67% |
2023 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -₹1.63Cr | ↓2.98% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 33.69% | 13.32 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0.03% | ||
Retail Investors | 66.29% | ||
Others | 0% | 0.00 |
Oxygenta Pharmaceutical Ltd’s net profit jumped 286.95% since last year same period to ₹8.02Cr in the Q4 2023-2024. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated 312.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Oxygenta Pharmaceutical Ltd is currently in a Bearish trading position according to technical analysis indicators.
Oxygenta Pharmaceutical Ltd (524636) share price today is ₹32.7
Oxygenta Pharmaceutical Ltd is not listed on NSE
Oxygenta Pharmaceutical Ltd is listed on BSE
Today’s traded volume of Oxygenta Pharmaceutical Ltd(524636) is 8,920.00.
Today’s market capitalisation of Oxygenta Pharmaceutical Ltd(524636) is ₹114.43Cr.
Oxygenta Pharmaceutical Ltd(524636 | Price |
---|---|
52 Week High | ₹52.27 |
52 Week Low | ₹25.02 |
Oxygenta Pharmaceutical Ltd(524636) share price is ₹32.7. It is down -37.44% from its 52 Week High price of ₹52.27
Oxygenta Pharmaceutical Ltd(524636) share price is ₹32.7. It is up 30.70% from its 52 Week Low price of ₹25.02
Oxygenta Pharmaceutical Ltd(524636 | Returns |
---|---|
1 Day Returns | 0.45% |
1 Month Returns | -10.39% |
3 Month Returns | -17.54% |
1 Year Returns | -17.39% |